Cargando…
Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
OBJECTIVES: Contrast-induced nephropathy is considered a serious complication following coronary angiography increasing morbidity and mortality. Various drugs have been assessed to reduce the incidence of contrast-induced nephropathy. In this study, we compared trimetazidine and allopurinol as a pha...
Autores principales: | Galal, Haitham, Shehta, Mahmoud, Attia, Sameh, Bastawy, Islam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Heart Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721453/ https://www.ncbi.nlm.nih.gov/pubmed/33299790 http://dx.doi.org/10.37616/2212-5043.1146 |
Ejemplares similares
-
Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency
por: Ye, Ziliang, et al.
Publicado: (2017) -
Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial
por: Iranirad, Leili, et al.
Publicado: (2017) -
Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021) -
Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Bidram, Peyman, et al.
Publicado: (2015) -
Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2017)